Mercurial > repos > proteore > proteore_expression_levels_by_tissue
diff README.rst @ 4:f294fd77b143 draft
planemo upload commit 08f1831e097df5d74bf60ff5955e7e9c8e524cc8-dirty
author | proteore |
---|---|
date | Wed, 14 Mar 2018 12:22:51 -0400 |
parents | d7f909ae24d9 |
children | 2c0bab71a436 |
line wrap: on
line diff
--- a/README.rst Wed Mar 07 09:56:25 2018 -0500 +++ b/README.rst Wed Mar 14 12:22:51 2018 -0400 @@ -13,9 +13,11 @@ ------------------------------------------------- -This tool retrieve information from Human Protein Atlas (https://www.proteinatlas.org/) regarding the expression profiles of human genes both on the mRNA and protein level. +This tool retrieve information from Human Protein Atlas (https://www.proteinatlas.org/) +regarding the expression profiles of human genes both on the mRNA and protein level. -A list of ENSG (Ensembl gene) IDs must be entered (either via a copy/paste or by choosing a file), if it's not the case, please use the ID_Convert tool from ProteoRE. +A list of ENSG (Ensembl gene) IDs must be entered (either via a copy/paste or by choosing a file), +if it's not the case, please use the ID_Convert tool from ProteoRE. The resources from Human Protein Atlas that can be queried are the following: @@ -29,4 +31,25 @@ The tab-separated file includes Ensembl gene identifier ("Gene"), gene name ("Gene name"), tumor name ("Cancer"), the number of patients annotated for different staining levels ("High", "Medium", "Low" & "Not detected") and log-rank p values for patient survival and mRNA correlation ("prognostic - favourable", "unprognostic - favourable", "prognostic - unfavourable", "unprognostic - unfavourable"). - The data is based on The Human Protein Atlas version 18 and Ensembl version 88.38. \ No newline at end of file + The data is based on The Human Protein Atlas version 18 and Ensembl version 88.38. + +----- + +**Reliability score** + +Reliability score is divided into Enhanced, Supported, Approved, or Uncertain with respect +to the definitions from HPA: + +Enhanced - One or several antibodies with non-overlapping epitopes targeting the same gene +have obtained enhanced validation based on orthogonal or independent antibody validation method. + +Supported - Consistency with RNA-seq and/or protein/gene characterization data, +in combination with similar staining pattern if independent antibodies are available. + +Approved - Consistency with RNA-seq data in combination with inconsistency with, or lack of, +protein/gene characterization data. Alternatively, consistency with protein/gene characterization data +in combination with inconsistency with RNA-seq data. If independent antibodies are available, +the staining pattern is partly similar or dissimilar. + +Uncertain - Inconsistency with, or lack of, RNA-seq and/or protein/gene characterization data, +in combination with dissimilar staining pattern if independent antibodies are available.